These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34097495)

  • 1. Diversity of Sequence Types and Impact of Fitness Cost among Carbapenem-Resistant Acinetobacter baumannii Isolates from Tripoli, Libya.
    Abou Fayad AG; Haraoui LP; Sleiman A; Jaafar M; Zorgani A; Matar GM; Higgins PG
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0027721. PubMed ID: 34097495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolated from three major hospitals in Jordan.
    Ababneh Q; Aldaken N; Jaradat Z; Al Sbei S; Alawneh D; Al-Zoubi E; Alhomsi T; Saadoun I
    Int J Clin Pract; 2021 Dec; 75(12):e14998. PubMed ID: 34714567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii from Colombian Hospitals.
    Correa A; Del Campo R; Escandón-Vargas K; Perenguez M; Rodríguez-Baños M; Hernández-Gómez C; Pallares C; Perez F; Arias CA; Cantón R; Villegas MV
    Microb Drug Resist; 2018; 24(1):48-54. PubMed ID: 28570118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Egypt: Clonal Spread of blaOXA-23.
    El Bannah AMS; Nawar NN; Hassan RMM; Salem STB
    Microb Drug Resist; 2018 Apr; 24(3):269-277. PubMed ID: 28783427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolution of carbapenem resistance determinants and major epidemiological lineages among carbapenem-resistant Acinetobacter baumannii isolates in Germany, 2010-2019.
    Wohlfarth E; Kresken M; Higgins PG; Stefanik D; Wille J; Hafner D; Körber-Irrgang B; Seifert H;
    Int J Antimicrob Agents; 2022; 60(5-6):106689. PubMed ID: 36375774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates reveals the emergence of bla
    Kumar S; Patil PP; Singhal L; Ray P; Patil PB; Gautam V
    Infect Genet Evol; 2019 Nov; 75():103986. PubMed ID: 31362071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and molecular characterizations of carbapenem-resistant Acinetobacter baumannii isolates collected within the EURECA study.
    Kostyanev T; Xavier BB; García-Castillo M; Lammens C; Bravo-Ferrer Acosta J; Rodríguez-Baño J; Cantón R; Glupczynski Y; Goossens H;
    Int J Antimicrob Agents; 2021 Jun; 57(6):106345. PubMed ID: 33887390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology and genetic characterisation of carbapenem-resistant Acinetobacter baumannii isolates from Guangdong Province, South China.
    Jiang L; Liang Y; Yao W; Ai J; Wang X; Zhao Z
    J Glob Antimicrob Resist; 2019 Jun; 17():84-89. PubMed ID: 30445207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial Outbreak of Extensively Drug-Resistant Acinetobacter baumannii Isolates Containing
    Hujer AM; Higgins PG; Rudin SD; Buser GL; Marshall SH; Xanthopoulou K; Seifert H; Rojas LJ; Domitrovic TN; Cassidy PM; Cunningham MC; Vega R; Furuno JP; Pfeiffer CD; Beldavs ZG; Wright MS; Jacobs MR; Adams MD; Bonomo RA
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28893775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of Carbapenem-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clinical Isolates Collected from Some Libyan Hospitals.
    Mathlouthi N; Areig Z; Al Bayssari C; Bakour S; Ali El Salabi A; Ben Gwierif S; Zorgani AA; Ben Slama K; Chouchani C; Rolain JM
    Microb Drug Resist; 2015 Jun; 21(3):335-41. PubMed ID: 25587875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endemic carbapenem-nonsusceptible
    Saharman YR; Karuniawati A; Sedono R; Aditianingsih D; Sudarmono P; Goessens WHF; Klaassen CHW; Verbrugh HA; Severin JA
    Antimicrob Resist Infect Control; 2018; 7():5. PubMed ID: 29344351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Investigation of Carbapenem-Resistant Acinetobacter spp. from Hospitals in North Rhine-Westphalia, Germany.
    Rieber H; Frontzek A; Pfeifer Y
    Microb Drug Resist; 2017 Jan; 23(1):25-31. PubMed ID: 27093111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acinetobacter baumannii strains isolated from cerebrospinal fluid (CSF) and bloodstream analysed by cgMLST: the dominance of clonal complex CC92 in CSF infections.
    Chen T; Fu Y; Hua X; Xu Q; Lan P; Jiang Y; Yu Y; Zhou Z
    Int J Antimicrob Agents; 2021 Oct; 58(4):106404. PubMed ID: 34298091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insertion sequences and sequence types profile of clinical isolates of carbapenem-resistant A. baumannii collected across India over four year period.
    Vijayakumar S; Anandan S; Ms DP; Kanthan K; Vijayabaskar S; Kapil A; Ray P; Sistla S; Bhattacharya S; Wattal C; Thirunarayan ; Deotale V; Mathur P; Walia K; Ohri VC; Veeraraghavan B
    J Infect Public Health; 2020 Jul; 13(7):1022-1028. PubMed ID: 31874816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of
    Słoczyńska A; Wand ME; Tyski S; Laudy AE
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33801221
    [No Abstract]   [Full Text] [Related]  

  • 17. Multilocus Sequence Typing of Carbapenem-Resistant
    Alam M; Rasool MH; Khan I; Khurshid M; Aslam B
    Microb Drug Resist; 2022 Oct; 28(10):997-1002. PubMed ID: 35985003
    [No Abstract]   [Full Text] [Related]  

  • 18. Acinetobacter baumannii analysis by core genome multi-locus sequence typing in two hospitals in Bolivia: endemicity of international clone 7 isolates (CC25).
    Cerezales M; Xanthopoulou K; Wille J; Bustamante Z; Seifert H; Gallego L; Higgins PG
    Int J Antimicrob Agents; 2019 Jun; 53(6):844-849. PubMed ID: 30928684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissemination of bla
    Leungtongkam U; Thummeepak R; Wongprachan S; Thongsuk P; Kitti T; Ketwong K; Runcharoen C; Chantratita N; Sitthisak S
    Microb Drug Resist; 2018; 24(1):55-62. PubMed ID: 28594634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
    Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.